US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 308.600.2700+0.09%19:56 EDT

Volume:355.16K

Turnover:107.82M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.72%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study

Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Inhibikase Therapeutics (IKT)

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?

Simply Wall St.

Press Release: Spectral AI Announces 2026 Second Quarter Financial Results

Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity

Sector Update: Healthcare

MT Newswires Live

National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability

Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)

Analyst David Kwan Reiterates Buy on HEALWELL AI, Citing Strong Healthcare AI Positioning, Margin Expansion, and SpaceX Stake Monetization Upside

DRI Healthcare (DHT.UN) Gets a Buy from CIBC

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)

Achieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target

Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63

Sector Update: Healthcare

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":355161,"hourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Not Yet Opened","change":-8.87,"latestTime":"08-24 16:00:00 EDT","open":314.79,"high":315.4,"low":293,"amount":107824162.61835,"amplitude":0.070618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"volumeRatio":0.701444,"impliedVol":0.977,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.701444,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"eps":0,"divideRate":0.003292,"volume":355161,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658416509","title":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658416509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658416509?lang=en_us&edition=fundamental","pubTime":"2026-08-12 07:20","pubTimestamp":1786490407,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neurogene (NGNE) and Cardiff Oncology (CRDF). Neur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","NGNE","BK4585","LABU","HCSG","BK4588","BK4137","CRDF","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493229","title":"Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493229?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:54","pubTimestamp":1786485274,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Intelligent Bio Solutions ( ($INBS) ). On August 11, 2026, Intelligent Bio Solutions announced it had completed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fda-fingerprinting-drug-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fda-fingerprinting-drug-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949348","title":"Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Inhibikase Therapeutics (IKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949348?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:50","pubTimestamp":1786485007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mereo Biopharma Group Plc (MREO) and Inhibikase Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-and-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-and-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4581","LU0029874061.USD","BK4585","BK4588","XBI","MREO","BK4505","BK4139","BK4137","HCSG","LU0128526141.USD","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994577","title":"Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994577","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994577?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:49","pubTimestamp":1786481371,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc. ADR ( ($BLTE) ) has provided an announcement. On August 11, 2026, Belite Bio announced that the U.S. Food and Drug Administration ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/belite-bio-wins-fda-priority-review-for-tinlarebant-in-stargardt-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/belite-bio-wins-fda-priority-review-for-tinlarebant-in-stargardt-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","AADR","DINT","DIVL","SAPH","CVY","BK4585","APIE","ARMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946437","title":"What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946437?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:45","pubTimestamp":1786481115,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE:ABBV) said the FDA has accepted for review a supplemental Biologics License Application for BOTOX Cosmetic to treat masseter muscle prominence in the U.S.\nThe filing positions BOTOX Cosmetic as a potential first approved neurotoxin for this jawline contouring indication, expanding AbbVie’s facial aesthetics reach beyond wrinkle treatment.\nAbbVie is seeking to build on Phase 3 data that supported efficacy and safety in adults seeking non surgical jawline contouring...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2089284900.SGD","LU2237443465.HKD","SG9999001440.SGD","PPH","GLAM","LU1670627923.USD","LU0310800379.SGD","IXJ","LU1061106388.HKD","LU0198837287.USD","JDOC","LU0128525929.USD","LU0234570918.USD","LU1496350171.SGD","LU2089283258.USD","LU0289739699.SGD","LU1074936037.SGD","XLV","LU2125909593.SGD","ABBV","IE00BFTCPJ56.SGD","LU0203345920.USD","RXL","LU0965508806.USD","IE0009355771.USD","LU2237443622.USD","IE0000B7K699.USD","IE000BZT7R73.USD","FTXH","BK4534","LU0882574055.USD","LU0868494708.USD","IYH","LABU","LU0289961442.SGD","LU1732799900.SGD","TRUH","LU2237443895.HKD","MEDX","VHT","IE0002270589.USD","IE00BJJMRZ35.SGD","IE00BVYPNW00.USD","PJP","IE000SO60NU8.SGD","LU2347655156.SGD","AGNG","LU2089984988.USD","FHLC","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948230","title":"Press Release: Spectral AI Announces 2026 Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948230?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"Indication; with this classification, Spectral AI is now authorized to. commence commercial distribution activities in the United States.-- In March 2026, awarded $31.7 million of advanced funding from the. accelerate and support additional development and procurement for the. -- Following the receipt of FDA clearance for the DeepView System, drew $6.5. million under our existing credit facility with Avenue Capital Group,providing non-dilutive capital to further strengthen the Company's. -- Expanded leadership team in advance of commercial activities, including. the appointments of David McGuire as Chief Financial Officer and Darcy. -- Completed all remaining milestones under our Department of Defense. contract for the DeepView System handheld device, contracted through the. Medical Technology Enterprise Consortium , including the delivery. -- Commenced label expansion of the DeepView System to include heads, hands","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","QTOC","ARTY","MDAI","AIPO","VTHR","BK4082","LABU","BK4232","CHAT","BK4585","R","BK4022","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991075","title":"Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991075","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991075?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:35","pubTimestamp":1786476926,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Achieve Life Sciences, with a price target of $17.00. P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-rating-on-achieve-life-sciences-with-unchanged-17-price-target-backed-by-cytisinicline-launch-readiness-and-fda-pathway-clarity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-rating-on-achieve-life-sciences-with-unchanged-17-price-target-backed-by-cytisinicline-launch-readiness-and-fda-pathway-clarity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891047","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891047?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:28","pubTimestamp":1786476514,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Tuesday afternoon, with the NYSE Healthcare Index shedding 0.4% and the State Street Health Care Select Sector SPDR ETF  down 0.2%.The iShares Biotechnology ETF  decreased 0.2%.In corporate news, Tactile Systems Technology  shares fell nearly 18% after it reported late Monday its Q2 results and lowered its revenue guidance for the full year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","BK4581","BK4137","BK4082","HCSG","BK4585","BK4588","LU0128526141.USD","TCMD","LU0029874061.USD","LABU","XLV","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910278","title":"National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910278?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:18","pubTimestamp":1786475918,"startTime":"0","endTime":"0","summary":"National Healthcare ( ($NHC) ) has issued an update. On August 6, 2026, National HealthCare Corporation announced it will pay a quarterly cash divi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4581","BK4585","BK4588","XBI","BK4185","NHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221910","title":"Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221910","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221910?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:05","pubTimestamp":1786475121,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on UPB stock, giving a Buy rating today. Matt Phipps has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4588","BK4139","LU2065732104.USD","UPB","PRGS","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910604","title":"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910604?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:00","pubTimestamp":1786474815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL) and Cronos Group (CRON) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MJ","BK4588","BK4137","LU0128526141.USD","HCSG","YOLO","XLV","CRON","LABU","LU0029874061.USD","BK4581","BK4007","AUTL","BK4585","BK4557","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991062","title":"Analyst David Kwan Reiterates Buy on HEALWELL AI, Citing Strong Healthcare AI Positioning, Margin Expansion, and SpaceX Stake Monetization Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991062?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:55","pubTimestamp":1786474544,"startTime":"0","endTime":"0","summary":"HEALWELL AI, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Kwan from TD Cowen maintained a Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-david-kwan-reiterates-buy-on-healwell-ai-citing-strong-healthcare-ai-positioning-margin-expansion-and-spacex-stake-monetization-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-david-kwan-reiterates-buy-on-healwell-ai-citing-strong-healthcare-ai-positioning-margin-expansion-and-spacex-stake-monetization-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELOL","MARS","WSPC","LU2290526834.HKD","LOFF","UFO","BK4588","DXYZ","QTOC","WARP","SPCX","SPAL","XLV","SPCH","SPCG","BK4089","SPCM","AIPO","ORBX","HAIAU","CHAT","VTHR","BK4615","LU1861558580.USD","BK4581","SPAX","SNK","BK4585","AGIX","LU1861220033.SGD","XOVR","SPCU","LU2360107168.USD","SPCQ","SSPC","LU1861559042.SGD","XBI","LU1861215975.USD","ARTY","LOFD","LABU","SPCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910886","title":"DRI Healthcare (DHT.UN) Gets a Buy from CIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910886?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:36","pubTimestamp":1786473381,"startTime":"0","endTime":"0","summary":"CIBC analyst Erin Kyle maintained a Buy rating on DRI Healthcare today and set a price target of C$21.00. Kyle covers the Technology sector, focusi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-gets-a-buy-from-cibc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-gets-a-buy-from-cibc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4581","BK4588","LU0029874061.USD","TECS","XLV","HCSG","BK4137","LU0154245756.USD","LU0154245673.USD","DRI","LU0128526141.USD","BK4585","LABU","XBI","BK4504","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658433917","title":"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658433917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658433917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:10","pubTimestamp":1786471809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","LU0128526141.USD","BK4588","HCSG","BK4139","SBIO","XLV","BK4581","PSIL","BK4585","LU0053671581.USD","SGRY","LU0029874061.USD","LABU","XBI","BK4137","BK4007","RLMD","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791274","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791274?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:40","pubTimestamp":1786470008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Bi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","CANC","HCSG","BK4585","IMUX","LEGN","MEDI","MEMS","XLV","LABU","BK4581","BK4139","BK4505","BK4137","LU0029874061.USD","SGMT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912744","title":"J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912744?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469755,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Bansi Desai maintained a Buy rating on Fortis Healthcare Ltd. yesterday and set a price target of INR1,180.00. The company’s sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAI","LABU","LU0106831901.USD","BK4534","LU0971096721.USD","LU1244550577.SGD","LU0528227936.USD","LU1989772923.USD","LU1162221912.USD","IE00B775SV38.USD","LU2347655156.SGD","LU2487616109.SGD","LU0390134368.USD","IE00BKVL7J92.USD","LU1363072403.SGD","XBI","LU2133065610.SGD","LU0912757837.SGD","LU2089283258.USD","LU0158827781.USD","BK4516","LU0795875169.SGD","LU0029874061.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0006306889.USD","LU1732800096.USD","HCSG","LU1074936037.SGD","LU2271345857.HKD","LU0158827948.USD","BK4137","BK4585","LU1548497426.USD","LU0225283273.USD","LU1720051108.HKD","LU0234570918.USD","LU2023251221.USD","KBWB","LU0210528500.USD","XLV","LU0106261372.USD","LU0882574139.USD","LU1720051017.SGD","IE00B3S45H60.SGD","LU0320765646.SGD","LU2111349929.HKD","LU1791710582.SGD","LU1668664300.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912719","title":"Achieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912719","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912719?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469751,"startTime":"0","endTime":"0","summary":"Analyst Brandon Folkes of H.C. Wainwright reiterated a Buy rating on Achieve Life Sciences, retaining the price target of $12.00. Brandon Folkes ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/achieve-maintains-strong-cash-position-and-clear-fda-path-brandon-folkes-reiterates-buy-rating-and-unchanged-12-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/achieve-maintains-strong-cash-position-and-clear-fda-path-brandon-folkes-reiterates-buy-rating-and-unchanged-12-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658291273","title":"Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291273","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658291273?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469744,"startTime":"0","endTime":"0","summary":"Neurogene, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Dolezal from LifeSci Capital maintained a B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658644912","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658644912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658644912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:15","pubTimestamp":1786468518,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.4%.The iShares Biotechnology ETF  rose 0.3%In corporate news, Hims & Hers Health  shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2028103732.USD","LU1244550494.USD","LU1989772840.SGD","LU1668664300.SGD","LU2089283258.USD","LU0971096721.USD","LU1732800096.USD","LU1244550221.USD","LU0390134368.USD","LU1162221912.USD","LU2487616109.SGD","BK4196","LU0314104364.USD","LU0158827948.USD","LU0106831901.USD","LU1720051017.SGD","LU2271345857.HKD","LU0098860793.USD","LU2347655156.SGD","LU1548497426.USD","LU0912757837.SGD","LU2089284900.SGD","XLV","BK4588","LU0006306889.USD","LU0882574139.USD","IE00B3S45H60.SGD","LU0158827781.USD","LU0557290698.USD","BK4585","BK4516","LU0267386448.USD","LU1988902786.USD","HIYY","LU1989772923.USD","LU1074936037.SGD","MS","GLAM","HIMY","LU0528227936.USD","LU0225283273.USD","LU1791710400.SGD","LU1791710582.SGD","LU0106261372.USD","IE00BZ1G4Q59.USD","BK4127","IE00B775SV38.USD","IE00BKVL7J92.USD","HIMS","BK4581","LABU","BK4534","LU2357305700.SGD","HMYY","LU2133065610.SGD","HIMZ","LU2023251221.USD","LU1363072403.SGD","IBB","LU0053666078.USD","HEAL","LU0234570918.USD","LU0320765646.SGD","LU2111349929.HKD","LU1244550577.SGD","THNR","LU0210528500.USD","BK4504","LU1064131342.USD","IAI","LU1720051108.HKD","XBI","KBWB","LU1732799900.SGD","LU2264538146.SGD","LU0795875169.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911286","title":"Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911286?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462847,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurosense Therapeutics Ltd. (NRSN) and Brookdale Se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2190626999.HKD","BK4581","BK4137","BK4185","HCSG","LU0128526141.USD","LU0842063009.USD","BKD","LU1499592464.USD","NRSN","XBI","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":19,"totalSize":401,"code":"91000000","status":"200"}]}}